Context Therapeutics Stock Forecast

Sell candidate since Jun 02, 2026 Loss -27.69%

The Context Therapeutics Inc. stock price fell by -13.79% on the last day (Friday, 5th Jun 2026) from $2.03 to $1.75. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 19.13% from a day low at $1.73 to a day high of $2.06. The price has fallen in 6 of the last 10 days and is down by -27.08% for this period. Volume has increased on the last day by 229 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 819 thousand shares were bought and sold for approximately $1.43 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.00) are considered to be a "second chance" to get out. According to the fan-theory $1.10 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

CNTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Context Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.39 and $2.38. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -41.28%. Further fall is indicated until a new bottom pivot has been found. Context Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Context Therapeutics Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.330 between high and low, or 19.13%. For the last week, the stock has had daily average volatility of 14.10%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTX) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Context Therapeutics Inc. to open at $1.84, and during the day (based on 14 day Average True Range), to move between $1.64 and $1.86, which gives a possible trading interval of +/-$0.219 (+/-13.37%) up or down from last closing price. If Context Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 13.37% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.03, some $0.280 (16.00%) from the current price of $1.75, our system finds the risk reward not very attractive.

Is Context Therapeutics Inc. stock A Buy?

Context Therapeutics Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -8.219 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.84 ( 5.33%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk